Utilization of cartilage graft technology for the testing of novel chondro‐therapeutic agents
Authors: Hall Amanda , Hayes Anthony , Brown Liesbeth , Tubo Ross , Caterson Bruce 
Published: August 2004

Introduction  The aims of the current study were to (i) tissue engineer a cartilage graft with structural and biochemical properties of native articular cartilage in vivo, with potential for use in cartilage repair technologies and (ii) utilize this model as a test system to evaluate the efficiency of novel therapeutics for future research into cartilage metabolism in health and disease.Materials and methods  Articular cartilage was harvested from hock joints of (young) 7‐day and (old) 18‐month bovine sources. Cells were isolated by enzymatic digestion and seeded at a range of cell densities (2, 4, 6, 8, 10 and 12 × 106 cells/insert) into type II collagen‐coated Millipore filter inserts and cultured as described previously (Kandel et al. 1995). In order to mimic a catabolic effect on cartilage, some samples were treated with IL‐1α (10 ng/ml) for 24 h in the absence or presence of experimental drugs. Proteoglycan (PG) release, detectable in the medium, was analysed by colorimetric assay (Farndale et al. 1986). At the end of the culture period, cartilage grafts were fixed, sectioned and stained with Alcian Blue or immuno‐fluorescently labelled with a panel of monoclonal antibodies recognizing several components of the graft extracellular matrix.Results  Full‐depth chondrocytes from both young and old bovine sources produced a stratified hyaline tissue with distinct zones after 2 weeks in culture. These zones approximated to the surface, middle and deep zones that characterize native articular cartilage in vivo. Increased culture time and seeding density produced cartilage of an increased thickness and cellularity, respectively. Grafts produced from young cartilage contained approximately 3 times more sulfated PG than grafts produced from an old cartilage, indicating an increased matrix secretion in these cultures. Histologically, the old grafts were also thinner and more weakly stained with Alcian Blue, indicating a lower sulfated PG content. Addition of IL‐1α to the cultures resulted in a dramatic PG release from the cartilage grafts, manifest histologically as a loss of Alcian Blue staining in the upper third of the cartilage tissue. Immunofluorescent staining identified subtle changes in matrix composition and in the structure and catabolism of matrix proteoglycans in response to both IL‐1a and the experimental drugs tested.Discussion  The grafts produced had many structural and biochemical similarities to articular cartilage in vivo. These grafts may better integrate with the host cartilage in cartilage repair procedure. This culture system also provides ideal conditions to analyse the response of engineered grafts to catabolic factors that occur in the arthritic joint, along with ideal conditions for research into drug therapies. Advantages of this culture system, in comparison with an explant system, are that effects can be analysed within a 24‐h period. Future work will include applying fatty acids, modified glucosamine and some Asian herbal remedies to this culture system and analysing their potential chondroprotective effects.